Long-form, data-driven studies on 1.6M+ filings across 43 markets. Comparative regulation, walk-forward backtests, profiles, market mechanics.
Kaufman & Broad’s CEO sold EUR 426,400 as French housing stays weak, rates stay sticky and the company keeps taking share.
Getlink’s board filed two July 28 sales as the tunnel operator follows a strong H1, raised guidance and a 24% year-to-date share gain.
Voyageurs du Monde drew a EUR 182m filing after a tender offer at EUR 180 a share. The bull case is real, but so are the limits.
Allegion’s VP, Controller and CAO sold after a strong Q2 and raised guidance. The filing sits inside a 6-insider cluster.
Travelers insiders sold in a late-July cluster, including Yin Daniel Tei-Hwa’s EUR 2.43m filing, as P&C pricing cools and peers rerate.
Twist Bioscience shares fell 4.13% as a 5-insider selling cluster and a July 23 sell-to-cover filing hit ahead of Aug. 3 results.
Two Enerpac directors sold 5,860 shares after the SFE acquisition announcement. Here is how the filings sit beside the July 8 deal and July 7 results.
ABC Arbitrage’s board seller filed two July 27 disposals as ECB rates, volatility and trading volumes shape the arb model and the stock.
Four insiders sold Opus Genetics on July 27 as the stock rose 8.77%. The biotech backdrop is strong, but the cluster changes the tone.
PubMatic CEO Rajeev Goel sold EUR 540k under a 10b5-1 plan. Here is how that filing reads against ad-tech, peers and the company’s Q1 guide.
Kaufman & Broad CEO Nordine Hachemi sold EUR 426,400 on July 27. Read the filing against French housing, rates, and peer positioning.
Skeena Resources drew a EUR 1.24m insider buy from CFO Andrew MacRitchie while gold miners stay bid and Eskay Creek advances.